Stuart A. Arbuckle

2012

In 2012, Stuart A. Arbuckle earned a total compensation of $4.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.

Compensation breakdown

Bonus$365,000
Non-Equity Incentive Plan$117,600
Option Awards$1,731,692
Salary$169,615
Stock Awards$2,131,308
Other$293,482
Total$4,808,697

Arbuckle received $2.1M in stock awards, accounting for 44% of the total pay in 2012.

Arbuckle also received $365K in bonus, $117.6K in non-equity incentive plan, $1.7M in option awards, $169.6K in salary and $293.5K in other compensation.

Rankings

In 2012, Stuart A. Arbuckle's compensation ranked 1,284th out of 11,487 executives tracked by ExecPay. In other words, Arbuckle earned more than 88.8% of executives.

ClassificationRankingPercentile
All
1,284
out of 11,487
89th
Division
Manufacturing
462
out of 4,252
89th
Major group
Chemicals And Allied Products
102
out of 1,200
92nd
Industry group
Drugs
58
out of 922
94th
Industry
Pharmaceutical Preparations
50
out of 697
93rd
Source: SEC filing on April 30, 2015.

Arbuckle's colleagues

We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2012.

2012

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2012

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2012

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2012

David Howton

Vertex Pharmaceuticals

Chief Legal Officer

2012

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2012

Kenneth Horton

Vertex Pharmaceuticals

Chief Legal Officer

News

You may also like